PCPC: State Legislation, ‘Fake Science,' FDA’s Sunscreen Monograph Among Top 2019 Challenges
The Personal Care Products Council’s top execs identified key legislative, regulatory and public affairs challenges facing industry in 2019 during a Feb. 26 panel discussion at the group’s annual meeting in Palm Beach, Fla.
You may also be interested in...
John Chave, director-general at Cosmetics Europe, says the European Commission’s plan for targeted assessment of 28 potential endocrine-disruptors in cosmetics – despite its conclusion in late 2018 that the current cosmetics regulatory framework adequately addresses endocrine-disruptor concerns – is symptomatic of a broad trend taking hold in Europe.
FDA is committed to working with Congress to update cosmetics regulations and its related authorities, as “we have not been able to expand the scope of what we’re able to do commensurate with the expansion and the scope of this industry,” Commissioner Scott Gottlieb told House appropriators Feb. 26.
The proposal under the state’s Safer Consumer Products regulation marks the ingredient for alternative analyses and potential replacement in nail-care products. California’s Department of Toxic Substances Control cites possible dangers to salon workers in particular, including nervous system, respiratory and developmental toxicity risks.